On January 24, 2013, Anthony Selwyn Tabatznik, who has served as a member of the board of directors of Actavis, Inc. since December 2, 2009, notified the company of his decision to resign from the board, effective immediately. Mr. Tabatznik's decision was not the result of any disagreement with the company, its management or the board of directors.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
- USD | -.--% |
|
+1.73% | +0.97% |
1st Jan change | Capi. | |
---|---|---|
+0.97% | 63.66B | |
+56.89% | 823B | |
+39.52% | 627B | |
-6.55% | 353B | |
+15.99% | 320B | |
+7.92% | 295B | |
+13.74% | 239B | |
+13.83% | 220B | |
-0.49% | 219B | |
+7.94% | 167B |
- Stock Market
- Equities
- AGN Stock
- News Allergan plc
- Actavis, Inc. Announces Resignation of Anthony Selwyn Tabatznik from the Board